Pharmacist's Letter
June Issue
 individualizing metformin add-ons in patients with type 2 diabetes
 Corlanor (CORE-lah-nore, ivabradine) will be the first new drug approved for systolic heart failure in a decade
 All Current Issue topics...
 View May Issue

 Browse Categories
 Bone/Joint and Rheumatology
 Diabetes and Endocrinology
 More Categories...

Exit Mobile

Login  | Issues  | Feedback  | Search  | Browse  | New Drugs  | Email Us  | More >

[*]Top | [#]Bottom